Endocrine Abstracts

Aim: Indications for Radioiodine (131I) in therapy for benign thyroid disease include Graves’ disease, Toxic goitre and euthyroid goitre. There is reduced clinical & financial implication as compared to surgery with absence of anaesthetic/invasive complications, pain, recovery and in-patient stay. The aim of this study was establishing demographics and prevalence of the treatment population, to ensure dosage and indication compliance with national guidelines as well a...